223 related articles for article (PubMed ID: 33257751)
1. Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.
Thomsen H; Li X; Sundquist K; Sundquist J; Försti A; Hemminki K
Sci Rep; 2020 Nov; 10(1):20887. PubMed ID: 33257751
[TBL] [Abstract][Full Text] [Related]
2. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
Liozon E; Ouattara B; Rhaiem K; Ly K; Bezanahary H; Loustaud V; Letellier P; Drouet M; Vidal E
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S89-94. PubMed ID: 19646354
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
4. [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].
Villiger PM
Z Rheumatol; 2017 Aug; 76(6):509-523. PubMed ID: 28638968
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of large vessel vasculitis].
Samson M; Bonnotte B
Rev Med Interne; 2016 Apr; 37(4):264-73. PubMed ID: 26620872
[TBL] [Abstract][Full Text] [Related]
6. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
7. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
9. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu's arteritis.
Hellmann DB
Curr Opin Rheumatol; 1993 Jan; 5(1):25-32. PubMed ID: 8094625
[TBL] [Abstract][Full Text] [Related]
11. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions.
Hemminki K; Li X; Sundquist J; Sundquist K
Arthritis Rheum; 2009 Mar; 60(3):661-8. PubMed ID: 19248111
[TBL] [Abstract][Full Text] [Related]
12. Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden.
Ji J; Dimitrijevic I; Sundquist J; Sundquist K; Zöller B
Scand J Rheumatol; 2017 Nov; 46(6):484-489. PubMed ID: 28276953
[TBL] [Abstract][Full Text] [Related]
13. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
[TBL] [Abstract][Full Text] [Related]
14. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
[TBL] [Abstract][Full Text] [Related]
15. Primary Large Vessel Vasculitis: Takayasu Arteritis and Giant Cell Arteritis.
Romero-Sanchez G; Dabiri M; Mossa-Basha M
Neuroimaging Clin N Am; 2024 Feb; 34(1):53-65. PubMed ID: 37951705
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.
Bengtsson BA; Malmvall BE
Arthritis Rheum; 1981 Jul; 24(7):899-904. PubMed ID: 7259802
[TBL] [Abstract][Full Text] [Related]
17. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.
Salvarani C; Gabriel SE; Gertz MA; Bjornsson J; Li CY; Hunder GG
Arthritis Rheum; 1994 Nov; 37(11):1621-6. PubMed ID: 7980674
[TBL] [Abstract][Full Text] [Related]
18. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis.
Weyand CM; Goronzy JJ
Curr Opin Rheumatol; 1995 Jan; 7(1):30-6. PubMed ID: 7718419
[TBL] [Abstract][Full Text] [Related]
19. [Management of polymyalgia rheumatica and large vessel vasculitis].
Hellmich B
Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
[TBL] [Abstract][Full Text] [Related]
20. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
Maksimowicz-McKinnon K; Clark TM; Hoffman GS
Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
